SEC Form 4 · accession 0000874015-15-000046
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Frank Bennett
Officer — SVP, Antisense Research
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 23, 2015 | M | 5,000 | $14.47 | A | 12,229 | D | |
| Common StockF1 | Mar 23, 2015 | S | 5,000 | $69.804 | D | 7,229 | D | |
| Common StockF1 | Mar 23, 2015 | M | 1,000 | $14.47 | A | 8,229 | D | |
| Common StockF1 | Mar 23, 2015 | S | 1,000 | $71.00 | D | 7,229 | D | |
| Common StockF1 | Mar 24, 2015 | M | 9,000 | $14.47 | A | 16,229 | D | |
| Common StockF1 | Mar 24, 2015 | S | 9,000 | $71.01 | D | 7,229 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $14.47 | Mar 23, 2015 | M | 6,000 | D | Jan 2, 2013 | Jan 1, 2016 | Common Stock | 6,000 | 26,909 | D |
| Employee Stock Option (right to buy) | $14.47 | Mar 24, 2015 | M | 9,000 | D | Jan 2, 2013 | Jan 2, 2016 | Common Stock | 9,000 | 17,909 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 2/20/2015.